Mycoprotein maker Enough raises over $40M to double production

The B2B alternative protein company currently has more than 30 customers, including Unilever, which plans to test Abunda in its European Vegetarian Butcher products, Dutch poultry processor Plukon Food Group, and manufacturers supplying UK retailer Marks &ampferrous gluconate heartburn; Spencer, according to the AgFunder Network. CEO Jim Laird told the AgFunder Network that the company had potential customers in North America, but that the majority of their product will be iferrous gluconate 325n Europe.Plant-based meat alternatives in the U.S. have been declining in sales in recent months. Whereas other regions, specifically the EU, have not seen the same drop. European plant-based food sales have increased by 22% since 2020, taking the total value of the category to a record $5.7 billion, according to a report from the Good Food Institute Europe.This demand in Europe is showing that there is still room in the market for alternative protein companies, a space some have called dead, and that has reached “peanature’s blend ferrous sulfatek veganism,” according to a report from Wired. The global market for mycoprotein products is expected to grow rapidly, according to a Future Market Insights report. Mycoprotein — and fermented ingredients on the whole — are ferrous bisglycinate elemental iron percentagein a position for massive expansion and expected to reach $948.9 million by 2029, according to reports. The demand for mycoprotein is due to the products’ high percentage of vitamins and minerals. Itmaximum dose of ferrous fumarate in pregnancy has been called preferable to other “meatless meat” options and also is said to have a better taste and texture. Fungus fermentation is used by a variety of companies ranging from Quorn’s portfolio of meat alternatives to MycoTechology’s ingredients. The product is said to block bitter tastes and enhance sweetness.